This is interesting. On December 14, TechnoFog noted the FDA gave approval to vaccine boosters amid 16 and 17-year-olds without consulting the medical advisory panel on safety and efficacy of the policy shift {SEE HERE}.
As correctly noted at the time, “This is the FDA making a cost/benefit calculation without knowing the costs or benefits. It doesn’t know the real risks, because it didn’t study the potential for adverse reactions in kids aged 16 – 17 years,” yet, the FDA did it anyway.

The issue is actually quite alarming considering there are multiple studies showing that specific age group, especially young males, were negatively impacted by vaccine created heart damage. Then again, adverse vaccine outcomes may have been the reason why the FDA never wanted to convene a medical advisory board before giving the approval for a vaccine booster to the group most at risk for the adverse outcome.
Regardless of FDA motive, the Washington Post is now following-up on the issue pointed out by Techno Fog and calling out the Biden administration for having the FDA ignore medical community advice:

Politico reports the discussions between Senator Manchin and the White House are at a stalemate, with the White House saying “
The article itself points to how Amtrak is suspending their vaccine mandate as a result of the federal courts blocking enforcement of any mandate pending litigation. From their perspective as a federal contractor, Amtrak is now in a position to cease the vaccine requirement until the legal issues are resolved. However, there’s an element touched upon that needs to be considered.